Nisa Investment Advisors
NMRA icon

Nisa Investment Advisors’s Neumora Therapeutics NMRA Stock Holding History

Nisa Investment Advisors’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49K Hold
1,466
– – ﹤0.01% 2727
2026
Q1 		$2.86K Hold
1,466
– – ﹤0.01% 2559
2025
Q4 		$2.62K Hold
1,466
– – ﹤0.01% 2570
2025
Q3 		$2.67K Hold
1,466
– – ﹤0.01% 2561
2025
Q2 		$1.07K Sell
1,466
-8,224
-85% -$6.23K ﹤0.01% 2721
2025
Q1 		$9.69K Buy
9,690
+4,872
+101% +$8.34K ﹤0.01% 2102
2024
Q4 		$51.1K Buy
4,818
+3,657
+315% +$43.8K ﹤0.01% 1677
2024
Q3 		$15.3K Buy
1,161
+1,102
+1,868% +$12.9K ﹤0.01% 1989
2024
Q2 		$580 Buy
59
+47
+392% +$486 ﹤0.01% 2653
2024
Q1 		$165 Buy
+12
New +$194 ﹤0.01% 2670

Other funds holding NMRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $5.44B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AH
Addis & Hill Wayne, Pennsylvania $181M AUM 21.74% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nisa Investment Advisors's NMRA Position: Q2 2026 in Review

Nisa Investment Advisors held its Neumora Therapeutics (NMRA) position steady in Q2 2026 at 1,466 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

Nisa Investment Advisors first reported a position in NMRA in Q1 2024 and has held it in 10 quarters since. The position peaked at $51.1K in Q4 2024. 37 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Nisa Investment Advisors held 1,466 shares of Neumora Therapeutics worth $2.49K as of Q2 2026.
  • Nisa Investment Advisors left its Neumora Therapeutics share count unchanged in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2727 holding.
  • Nisa Investment Advisors first reported a position in Neumora Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Nisa Investment Advisors's Neumora Therapeutics position peaked at $51.1K in Q4 2024.
  • 37 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.